You are here

Gritstone Oncology to Present at Leerink Partners Annual Global Healthcare Conference

EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Jean-Marc Bellemin, M.B.A., executive vice president and chief financial officer, and Karin Jooss, Ph.D., executive vice president of research and chief scientific officer, will present a company overview on Wednesday, February 27, 2019 at 10:30 a.m. EST during the 8th Annual SVB Leerink Global Healthcare Conference in New York.
Wednesday, February 20, 2019 - 16:00